Indonesia approves AstraZeneca vaccine for emergency use

Indonesia approves AstraZeneca vaccine for emergency use

Indonesia has approved AstraZeneca’s COVID-19 vaccine for emergency use, Penny K. Lukito, the chief of the country’s food and drug agency, told a news conference.

More than one million doses of the vaccine arrived late on Monday via the COVAX global vaccine-alliance scheme. About 38 million doses of a vaccine produced by China’s Sinovac Biotech have arrived in the Southeast Asian country so far, some of which have been used in a mass inoculation drive starting in January.

Source: reuters.com

Disclaimer: While every effort has been made to ensure accuracy, this article may contain minor inaccuracies in names, locations, or event details. Readers are welcome to contact the editorial team for any clarification.

Comments are closed.